CNP-102
/ Cour Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
March 29, 2024
Preclinical studies to determine myelin peptide-specific nanoparticle tolerance mechanisms and clinical translation
(IMMUNOLOGY 2024)
- "TIMP treatment also modulates spread epitope-specific T cells associated with disease progression, but not encapsulated within the TIMP, i.e. tissue-specific tolerance. Therefore, treatment activates various Ag-specific regulatory T cell subsets capable of inhibiting disease-associated autoantigens not encapsulated within the TIMP via release of immunoregulatory cytokines, and CNP-102 has proven efficacious in preclinical mouse models of MS."
Preclinical • Celiac Disease • CNS Disorders • Immunology • Multiple Sclerosis • CD4 • FOXP3 • IFNAR1 • IL10 • STING
March 23, 2024
Preclinical studies to determine myelin peptide-specific nanoparticle tolerance mechanisms and clinical translation
(IMMUNOLOGY 2024)
- "TIMP treatment also modulates spread epitope-specific T cells associated with disease progression, but not encapsulated within the TIMP, i.e. tissue-specific tolerance. Therefore, treatment activates various Ag-specific regulatory T cell subsets capable of inhibiting disease-associated autoantigens not encapsulated within the TIMP via release of immunoregulatory cytokines, and CNP-102 has proven efficacious in preclinical mouse models of MS."
Preclinical • Celiac Disease • CNS Disorders • Immunology • Multiple Sclerosis • CD4 • FOXP3 • IFNAR1 • IL10 • STING
February 04, 2024
Preclinical Studies to Determine Myelin Peptide-Specific Nanoparticle Tolerance Mechanisms and Clinical Translation
(ACTRIMS Forum 2024)
- "Treatment thus activates various Ag-specific regulatory T cell subsets capable of regulating responses to disease-relevant autoepitopes not encapsulated within the TIMP via release of immunoregulatory cytokines within the inflammatory site. Finally, the present data show the efficacy of CNP-102 in preclinical mouse models of MS."
Preclinical • Allergy • Celiac Disease • CNS Disorders • Immunology • Inflammation • Multiple Sclerosis • CD4 • FOXP3 • IFNA1 • IFNAR2 • IL10 • STING
1 to 3
Of
3
Go to page
1